Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-08-20FDA Approved: AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for amiloride hydrochloride and hydrochlorothiazide from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2020-08-20FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for HYDROCHLOROTHIAZIDE from Oxford Pharmaceuticals, LLC, authorizing regulatory approval for th…
-
FDA label_change · 2020-08-20FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) filed by Organon LLC, resulting in changes t…
-
FDA approval · 2020-08-20FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Leading Pharma, LLC)
The FDA approved a supplemental application for hydrochlorothiazide submitted by Leading Pharma, LLC.
-
FDA approval · 2020-08-20FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for the fixed-dose combination bisoprolol fumarate and hydrochlorothiazide from Teva Pharmaceuticals…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-08-20FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2020-08-20FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Fosinopril sodium and hydrochlorothiazide from Aurobindo Pharma Limited. The approval covers…
-
FDA approval · 2020-08-20FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for hydrochlorothiazide from Actavis Pharma, Inc., indicating a regulatory action on this drug (such…
-
FDA approval · 2020-08-20FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for Hydrochlorothiazide from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.), authori…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy [Phase 4]
Phase 4 trial comparing Candemore Plus Tab to Cantabell Tab for blood pressure lowering in patients with hypertension inadequately controlle…
-
FDA approval · 2020-08-20FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Diovan HCT (valsartan and hydrochlorothiazide) submitted by Novartis Pharmaceuticals Corpora…
-
FDA approval · 2020-08-20FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)
FDA approved a supplemental application for a generic fixed-dose combination of lisinopril and hydrochlorothiazide for hypertension.
-
FDA approval · 2020-08-20FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental (ANDA) application for a generic captopril and hydrochlorothiazide combination tablet submitted by Rising Ph…
-
FDA approval · 2020-08-20FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydrochlorothiazide from Teva Pharmaceuticals USA, Inc., granting an update to the generic produ…
-
FDA approval · 2020-08-20FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
The FDA approved a supplemental application for HYDROCHLOROTHIAZIDE from Oxford Pharmaceuticals, LLC.
-
FDA label_change · 2020-08-14FDA Approved: CLONIDINE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
FDA approved a supplemental application for clonidine from Ingenus Pharmaceuticals, LLC, resulting in updated labeling for the generic produ…
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Study of Cardiovascular Disease and Obstructive Sleep Apnea [Phase 2]
Phase 2 clinical trial on cardiovascular disease and obstructive sleep apnea has completed with posted results.
-
FDA approval · 2020-08-13FDA Approved: IRBESARTAN — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approved Solco Healthcare U.S., LLC's supplemental application for IRBESARTAN, authorizing the generic product's marketing.
-
FDA approval · 2020-08-07FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA granted a supplemental approval for the lisinopril and hydrochlorothiazide tablets from Exelan Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: Relative Bioavailability Study of Marketed and Lower Dose Ambrisentan in Healthy Adult Participants [Phase 1]
Phase 1 trial comparing relative bioavailability of marketed versus lower-dose ambrisentan in healthy adults; study completed with results p…
-
FDA approval · 2020-08-04FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved BluePoint Laboratories' supplemental application for clonidine hydrochloride (ANDA), granting a supplemental approval for t…
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Effects of Use of a Connected Pillbox On Medication Adherence [NA]
A completed clinical trial assessing how a connected pillbox affects medication adherence in patients with diabetes mellitus and hypertensio…
-
FDA approval · 2020-07-30FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for CAPTOPRIL AND HYDROCHLOROTHIAZIDE (Rising Pharma Holdings, Inc.), a combination antihypertensive…
-
FDA approval · 2020-07-29FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for hydrochlorothiazide from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
FDA approval · 2020-07-24FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
The FDA approved a supplemental application for ramipril (generic ramipril) filed by Chartwell RX, LLC., under ANDA 078745.